Literature DB >> 31434083

Changes in Cytokines, Haemodynamics and Microcirculation in Patients with Sepsis/Septic Shock Undergoing Continuous Renal Replacement Therapy and Blood Purification with CytoSorb.

Samuele Zuccari1, Elisa Damiani1, Roberta Domizi1, Claudia Scorcella1, Mario D'Arezzo2, Andrea Carsetti1, Simona Pantanetti1, Sara Vannicola1, Erika Casarotta1, Andrea Ranghino2, Abele Donati3, Erica Adrario1.   

Abstract

BACKGROUND: Extracorporeal blood purification therapies have been proposed as a strategy to remove inflammatory mediators during sepsis, thus improving outcome.
OBJECTIVES: We aimed to evaluate changes in cytokines, haemodynamics and microcirculation during blood purification with Cytosorb adsorber in septic patients.
METHODS: Prospective observational study on critically ill adult patients with sepsis/septic shock underwent renal replacement therapy (RRT) for acute renal failure and haemoadsorption with Cytosorb as adjunctive therapy for 24 h. Measurements were taken at baseline, after 6 and 24 h: haemodynamic parameters, arterial and central venous blood gases, plasma levels of tumour necrosis factor alpha, interleukin (IL) 1-beta, IL-6, IL-8 and IL-10. The sublingual microcirculation was assessed with sidestream dark field videomicroscopy to evaluate the perfused vessel density (PVD) and microvascular flow quality. Tissue oxygenation and microvascular reactivity were assessed with thenar near infrared spectroscopy (NIRS) with a vascular occlusion test.
RESULTS: Nine patients; plasma levels of IL-8 decreased at 24 h (p < 0.05 versus 6 h); no significant variation was found for other cytokines. Haemodynamic remained stable throughout the observation. Microvascular perfusion improved over time, with an increase in PVDs at 6 and 24 h (from 13.9 [13.3-16.4] to 15.7 [15-17.3] and 17 [14.8-18.6] mm/mm2 respectively, p = 0.003) and total vessel densities at 24 h (14.9 [13.9-16.9] vs. 17.9 [15.3-20], p = 0.0015). No significant variation was detected in NIRS-derived parameters. The Sequential Organ Failure Assessment score decreased from 12 ± 3 to 10 ± 1 at 24 h (p = 0.039).
CONCLUSIONS: In septic patients undergoing RRT, haemoadsorption with Cytosorb seems to determine a decreasing in plasma levels of IL-8, although levels of other cytokines did not vary significantly, and an improvement of microcirculation despite no significant variation in macro-haemodynamics.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Blood purification; Cytokines; Haemoadsorption; Sepsis; Septic shock; Sorbents; Sublingual microcirculation

Mesh:

Substances:

Year:  2019        PMID: 31434083     DOI: 10.1159/000502540

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  19 in total

Review 1.  Microcirculation: Physiology, Pathophysiology, and Clinical Application.

Authors:  Goksel Guven; Matthias P Hilty; Can Ince
Journal:  Blood Purif       Date:  2019-12-18       Impact factor: 2.614

Review 2.  Immunoregulatory therapy strategies that target cytokine storms in patients with COVID-19 (Review).

Authors:  Xianyao Wang; Zhixu He; Xing Zhao
Journal:  Exp Ther Med       Date:  2021-02-03       Impact factor: 2.447

3.  Effects of fish oil-containing nutrition supplementation in adult sepsis patients: a systematic review and meta-analysis.

Authors:  Hongyu Wang; Sen Su; Chao Wang; Jianhong Hu; Wu Dan; Xi Peng
Journal:  Burns Trauma       Date:  2022-06-10

4.  Use of CytoSorb® hemoadsorption column during prolonged cardiopulmonary bypass in complex cardiac surgery patient.

Authors:  Marianne Alarie; Maggie Savelberg; Danika Vautour; Igo B Ribeiro
Journal:  J Cardiothorac Surg       Date:  2022-07-07       Impact factor: 1.522

Review 5.  Advances in pediatric acute kidney injury.

Authors:  Rupesh Raina; Ronith Chakraborty; Abhishek Tibrewal; Sidharth K Sethi; Timothy Bunchman
Journal:  Pediatr Res       Date:  2021-03-17       Impact factor: 3.756

6.  Early Hemoperfusion for Cytokine Removal May Contribute to Prevention of Intubation in Patients Infected with COVID-19.

Authors:  Ali Esmaeili Vardanjani; Claudio Ronco; Hossein Rafiei; Mohamad Golitaleb; Mohammad Hoseyn Pishvaei; Mostafa Mohammadi
Journal:  Blood Purif       Date:  2020-06-26       Impact factor: 2.614

Review 7.  Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications.

Authors:  Alessandro Allegra; Mario Di Gioacchino; Alessandro Tonacci; Caterina Musolino; Sebastiano Gangemi
Journal:  Int J Mol Sci       Date:  2020-07-06       Impact factor: 5.923

8.  Can the cytokine adsorber CytoSorb® help to mitigate cytokine storm and reduce mortality in critically ill patients? A propensity score matching analysis.

Authors:  Christina Scharf; Ines Schroeder; Michael Paal; Martin Winkels; Michael Irlbeck; Michael Zoller; Uwe Liebchen
Journal:  Ann Intensive Care       Date:  2021-07-22       Impact factor: 6.925

9.  Early use of hemoadsorption in patients after out-of hospital cardiac arrest - a matched pair analysis.

Authors:  Muharrem Akin; Vera Garcheva; Jan-Thorben Sieweke; Ulrike Flierl; Hannah C Daum; Johann Bauersachs; Andreas Schäfer
Journal:  PLoS One       Date:  2020-11-03       Impact factor: 3.240

Review 10.  The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.

Authors:  Qing Ye; Bili Wang; Jianhua Mao
Journal:  J Infect       Date:  2020-04-10       Impact factor: 38.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.